Written questions by Kearns.

What recent assessment he has made of variation between NHS trusts in access to thromboprophylaxis during (a) pregnancy and (b) the postnatal period.

Awaiting answer.

How many and what proportion of women received a documented venous thromboembolism risk assessment postnatally in the most recent period for which data is available.

Awaiting answer.

What guidance his Department provides to help ensure that responsibility for prescribing anticoagulant prophylaxis in pregnancy and the puerperium is clear between GPs, maternity services and specialist teams.

Awaiting answer.

Whether his Department plans to (a) collect and (b) publish national data on the time taken to prescribe anticoagulant prophylaxis for pregnant women assessed as being at high risk of venous thromboembolism.

Awaiting answer.

What steps the Department is taking to improve the identification of women at elevated risk of venous thromboembolism in early pregnancy and before their first consultant review.

Awaiting answer.

Whether his Department plans to review whether current national venous thromboembolism risk assessment tools in pregnancy and the puerperium are sufficiently evidence-based.

Awaiting answer.

Whether his Department will make an assessment of the potential merits of introducing a national venous thromboembolism awareness campaign aimed at women during pregnancy and the postnatal period.

Awaiting answer.

What steps his Department is taking to help improve awareness of the signs and symptoms of venous thromboembolism among (a) pregnant and postnatal women and (b) clinicians.

Awaiting answer.

What assessment his Department has made of the potential impact of staffing levels on the timeliness of venous thromboembolism (a) assessment and (b) prevention.

Awaiting answer.

What assessment his Department has made of potential impact of second-generation antipsychotic drugs on levels of risk of venous thromboembolism.

Awaiting answer.

What targeted interventions are in place to help reduce inequalities in maternal outcomes .

Awaiting answer.

What recent assessment his Department has made of the adequacy of the level of education on (a) blood clots and (b) venous thromboembolism in the undergraduate midwifery syllabus.

Awaiting answer.

What steps his Department is taking to help ensure healthcare professionals understand the risks of venous thromboembolism in pregnancy and the puerperium, including failures to diagnose, prevent and assess risk.

Awaiting answer.

What assessment his Department has made of whether venous thromboembolism-related maternal mortality differs by (a) ethnicity, (b)deprivation, (c) geography, (d)disability and (c) age.

Awaiting answer.

Whether outcomes relating to venous thromboembolism in pregnancy will be routinely reported by demographic group.

Awaiting answer.

What assessment his Department has made of the levels of awareness amongst women of when and how to seek assessment for (a) deep vein thrombosis and (b) pulmonary embolism during pregnancy and the postnatal period.

Awaiting answer.

What training requirements exist for maternity professionals on recognising thromboembolism in pregnancy and the puerperium.

Awaiting answer.

How many and what proportion of NHS maternity units currently have dedicated maternal medicine pathways for complex venous thromboembolism risk.

Awaiting answer.

What steps his Department is taking to help improve awareness among healthcare professionals of the risk of venous thromboembolism associated with second-generation antipsychotic drugs.

Awaiting answer.

How many and what proportion of pregnant women receive a documented venous thromboembolism risk assessment following hospital admission in the most recent period for which data is available.

Awaiting answer.